Edmonton, Canada

Roman Szweda


Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 52(Granted Patents)


Company Filing History:


Years Active: 1996-2007

Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Roman Szweda

Introduction

Roman Szweda is a notable inventor based in Edmonton, Canada, recognized for his significant contributions to the field of pharmaceuticals. With a total of seven patents to his name, Szweda has made strides in developing innovative compounds that enhance drug efficacy and safety.

Latest Patents

One of Szweda's latest inventions involves rapamycin carbohydrate derivatives. This invention provides modified rapamycins that have specific monosaccharide(s), oligosaccharide(s), pseudosugar(s), or derivatives thereof attached through a linker. These modifications create rapamycin carbohydrate derivatives that exhibit enhanced pharmacokinetic and/or pharmacodynamic profiles. For instance, the administration of the rapamycin carbohydrate derivative results in altered pharmacokinetic profiles and reduced toxicities. Thus, this invention offers compounds with characteristics that are distinct from other drugs in its class, such as rapamycin. Another significant patent disclosed is the trisaccharide .alpha.-D-Glcp-(1-2)-.alpha.-D-Glcp-(1-3)-.alpha.-D-Glcp and related compounds, along with their pharmaceutical compositions.

Career Highlights

Throughout his career, Roman Szweda has worked with various organizations, including the Alberta Research Council Incorporated and Isotechnika Inc. His work has focused on advancing pharmaceutical research and developing innovative solutions to improve drug delivery and effectiveness.

Collaborations

Szweda has collaborated with notable professionals in his field, including Om P Srivastava and Ulrike Spohr. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Roman Szweda's innovative work in the pharmaceutical industry has led to the development of important compounds that enhance drug profiles and reduce toxicities. His contributions continue to impact the field positively, showcasing the importance of innovation in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…